25 years of CENTIS. Pandemic and Radiopharmaceuticals
Close to its 25th anniversary, CENTIS evaluates its work in the context of the disorders triggered by COVID-19. For this purpose, the situation of nuclear medicine and radiopharmacy, before and during the epidemic and their current development prospects is examined. The production of radiopharmaceut...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Centro de Gestión de la Información y Desarrollo de la Energía (CUBAENERGIA)
2020-12-01
|
Series: | Nucleus |
Subjects: | |
Online Access: | http://nucleus.cubaenergia.cu/index.php/nucleus/article/view/698 |
id |
doaj-c2d0a4c1869e457d8bca001016ef84cd |
---|---|
record_format |
Article |
spelling |
doaj-c2d0a4c1869e457d8bca001016ef84cd2020-12-06T15:09:19ZengCentro de Gestión de la Información y Desarrollo de la Energía (CUBAENERGIA)Nucleus0864-084X2075-56352020-12-0106769625 years of CENTIS. Pandemic and RadiopharmaceuticalsJ. Cruz Arencibia0R. Leyva Montaña1J. Morín Zorrilla2Centro de IsótoposCentro de IsótoposCentro de IsótoposClose to its 25th anniversary, CENTIS evaluates its work in the context of the disorders triggered by COVID-19. For this purpose, the situation of nuclear medicine and radiopharmacy, before and during the epidemic and their current development prospects is examined. The production of radiopharmaceuticals continues to be a consolidated global industry and although the pandemic affects this area, the presence of other diseases does not cease, so essential and critical nuclear medicine services are still needed, therefore its gradual reopening is expected. In addition, research will be taken with more strength, given that COVID-19 is so complex and associated with so many factors that it constitutes virgin terrain in perspective for diagnostic techniques in nuclear medicine. The role of therapeutic radiopharmaceuticals in an important set of diseases, especially cancer, will also remain. As a result, the Isotope Center focus its attention under good management practices, on the consolidation of the production and distribution of radiopharmaceuticals and in the development of new products. Both aspects are mainly based on two radionuclides: Tc-99m and Y-90.http://nucleus.cubaenergia.cu/index.php/nucleus/article/view/698radiofármacosradisótopostecnecio 99itrio 90coronavirususos terapéuticosproducción de isotopos |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
J. Cruz Arencibia R. Leyva Montaña J. Morín Zorrilla |
spellingShingle |
J. Cruz Arencibia R. Leyva Montaña J. Morín Zorrilla 25 years of CENTIS. Pandemic and Radiopharmaceuticals Nucleus radiofármacos radisótopos tecnecio 99 itrio 90 coronavirus usos terapéuticos producción de isotopos |
author_facet |
J. Cruz Arencibia R. Leyva Montaña J. Morín Zorrilla |
author_sort |
J. Cruz Arencibia |
title |
25 years of CENTIS. Pandemic and Radiopharmaceuticals |
title_short |
25 years of CENTIS. Pandemic and Radiopharmaceuticals |
title_full |
25 years of CENTIS. Pandemic and Radiopharmaceuticals |
title_fullStr |
25 years of CENTIS. Pandemic and Radiopharmaceuticals |
title_full_unstemmed |
25 years of CENTIS. Pandemic and Radiopharmaceuticals |
title_sort |
25 years of centis. pandemic and radiopharmaceuticals |
publisher |
Centro de Gestión de la Información y Desarrollo de la Energía (CUBAENERGIA) |
series |
Nucleus |
issn |
0864-084X 2075-5635 |
publishDate |
2020-12-01 |
description |
Close to its 25th anniversary, CENTIS evaluates its work in the context of the disorders triggered by COVID-19. For this purpose, the situation of nuclear medicine and radiopharmacy, before and during the epidemic and their current development prospects is examined. The production of radiopharmaceuticals continues to be a consolidated global industry and although the pandemic affects this area, the presence of other diseases does not cease, so essential and critical nuclear medicine services are still needed, therefore its gradual reopening is expected. In addition, research will be taken with more strength, given that COVID-19 is so complex and associated with so many factors that it constitutes virgin terrain in perspective for diagnostic techniques in nuclear medicine. The role of therapeutic radiopharmaceuticals in an important set of diseases, especially cancer, will also remain. As a result, the Isotope Center focus its attention under good management practices, on the consolidation of the production and distribution of radiopharmaceuticals and in the development of new products. Both aspects are mainly based on two radionuclides: Tc-99m and Y-90. |
topic |
radiofármacos radisótopos tecnecio 99 itrio 90 coronavirus usos terapéuticos producción de isotopos |
url |
http://nucleus.cubaenergia.cu/index.php/nucleus/article/view/698 |
work_keys_str_mv |
AT jcruzarencibia 25yearsofcentispandemicandradiopharmaceuticals AT rleyvamontana 25yearsofcentispandemicandradiopharmaceuticals AT jmorinzorrilla 25yearsofcentispandemicandradiopharmaceuticals |
_version_ |
1724398443361730560 |